HIV-1 RNA Quantitative RT-PCR with CD3/CD4/CD8 Immune Deficiency Panel (Panel 2) in UAE | 950 AED | 2026 DHA Guidelines

تحليل فيروس نقص المناعة البشرية 1 RNA الكمي بتقنية PCR في الوقت الحقيقي مع لوحة CD3/CD4/CD8 (لوحة نقص المناعة 2) في الإمارات | 950 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 Accredited Processing. HIV-1 RNA quantification with a lower limit of detection of 20 copies/mL.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM, Dubai/Abu Dhabi).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed physicians.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

الموجز التنفيذي

ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة وفق ISO 15189.
الخدمات اللوجستية الفاخرة: خدمة سحب الدم المنزلي بمعايير المستشفيات، مع سلسلة تبريد معتمدة ISO، وخدمة VIP المتنقلة.
الإرشاد السريري: استشارة هاتفية بعد الفحص لتفسير النتائج من قبل أطباء مرخصين من هيئة الصحة.
التأمين: تحقق مباشر من تغطية التأمين عبر واتساب +971545488731.

Overview

The HIV-1 RNA Quantitative RT-PCR with CD3/CD4/CD8 Immune Deficiency Panel combines viral load monitoring and lymphocyte subset profiling to provide a comprehensive immune status assessment for people living with HIV. This advanced panel aids in treatment optimization, detecting drug resistance signals, and predicting opportunistic infection risk.

Parameter	Our (Precision/ Method/ Speed)	Closest Alternative
HIV-1 RNA Quantification	qPCR (TaqMan®), LOD 20 copies/mL, report within 72 hrs	Standard RT-PCR, LOD 40 copies/mL, 5-7 days
Immune Cell Profiling	4-color Flow Cytometry (CD3/CD4/CD8 absolute counts & %) – dual-platform standardization	Single-platform CD4 only count, no CD3/CD8 ratio
Method	FDA-cleared, CE-IVD, ISO 15189 validated	Locally validated, limited external quality assurance
Turnaround	Sample Wed/Sat before 11am → Report Fri/Tue	Variable, often >1 week
Clinical Utility	Comprehensive → guides ART switching, prophylaxis decisions	Basic → limited insight into immune reconstitution

Physician Insight & Safety Protocol

“This combined panel provides a dynamic window into the immune-viral interplay. It is critical that the results are interpreted alongside the patient’s clinical history, current ART regimen, and any recent infections or vaccinations. Never alter antiretroviral therapy based solely on these numbers.”

— Dr. PRABHAKAR REDDY, Internal Medicine & HIV Specialist, DHA License 61713011

⚠ Medication Warning:

Do not discontinue or adjust any prescribed antiretroviral or prophylactic medication without consulting your treating physician. Abrupt changes can lead to viral rebound, drug resistance, and life-threatening immune deterioration.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: Active uncontrolled bleeding disorder (e.g., severe hemophilia); known allergy to antiseptic (chlorhexidine); inability to maintain cold chain for plasma separation within 2 hours.
Do NOT refrigerate or freeze whole blood for flow cytometry—transport at 18–22°C only.
Emergency Red Flags: Seek immediate medical attention if you experience sudden high fever, severe shortness of breath, altered mental status, or signs of opportunistic infection like new skin lesions or persistent diarrhea. These tests are for monitoring and do not replace emergency assessment.
For minors, testing requires informed consent of a legal guardian as per UAE CDS Law 2026.

Patient FAQ & Clinical Guidance

Q1: What exactly does HIV-1 RNA quantitative PCR with CD3/CD4/CD8 panel measure?

It measures the number of HIV-1 virus copies per milliliter of plasma and the absolute counts and percentages of T-lymphocyte subsets (CD3+, CD4+, CD8+). This dual evaluation reveals both the viral suppression level and the functional reserve of the immune system.

يقيس هذا الفحص عدد نسخ فيروس HIV-1 لكل مليلتر من البلازما بالإضافة إلى تعداد ونسب الخلايا اللمفاوية التائية (CD3+ وCD4+ وCD8+)، مما يكشف عن مستوى كبت الفيروس ومدى كفاءة الجهاز المناعي.

Q2: How should I prepare for the blood draw?

Fast for 12 hours before sample collection; only plain water is allowed. The phlebotomist will collect two lavender-top (EDTA) tubes and one green-top (sodium heparin) tube. Plasma must be separated within 2 hours, so inform the team if you have difficult veins.

يجب الصيام لمدة 12 ساعة قبل سحب العينة، مع شرب الماء العادي فقط. سيقوم الفني بسحب أنبوبين بغطاء بنفسجي (EDTA) وأنبوب بغطاء أخضر (هيبارين الصوديوم). يجب فصل البلازما خلال ساعتين، لذا يُرجى إخبار الفريق إذا كانت أوردتك صعبة.

Q3: When will I receive my report and can a doctor explain it to me?

Samples collected before 11 AM on Wednesday or Saturday are reported the following Friday or Tuesday, respectively. A DHA-licensed physician will call you to discuss your results, correlate them with your treatment, and guide any necessary follow-up.

يتم إصدار التقرير للعينات المسحوبة قبل الساعة 11 صباحًا يومي الأربعاء والسبت، يومي الجمعة والثلاثاء على التوالي. سيتصل بك طبيب مرخص من هيئة الصحة بدبي لمناقشة النتائج وربطها بعلاجك وتوجيهك لأي متابعة ضرورية.

دعم ثنائي اللغة متاح